Chie Ohmura

715 total citations
25 papers, 461 citations indexed

About

Chie Ohmura is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chie Ohmura has authored 25 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chie Ohmura's work include Diabetes Management and Research (9 papers), Diabetes Treatment and Management (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Chie Ohmura is often cited by papers focused on Diabetes Management and Research (9 papers), Diabetes Treatment and Management (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Chie Ohmura collaborates with scholars based in Japan. Chie Ohmura's co-authors include Ryuzo Kawamori, Hirotaka Watada, Yasushi Tanaka, Tomoaki Shimizu, Tomio Onuma, Hiroshi Uchino, Takahisa Hirose, Hidenori Yoshii, Akio Kanazawa and Tomoya Mita and has published in prestigious journals such as PLoS ONE, Diabetes Care and Endocrinology.

In The Last Decade

Chie Ohmura

24 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chie Ohmura Japan	13	211	105	94	86	70	25	461
Yunfei Pu China	9	176 0.8×	162 1.5×	95 1.0×	106 1.2×	178 2.5×	12	566
Shubham Soni Canada	10	210 1.0×	174 1.7×	193 2.1×	113 1.3×	171 2.4×	19	522
Malek Kechrid United States	5	82 0.4×	232 2.2×	76 0.8×	97 1.1×	61 0.9×	9	712
Alberto Sánchez‐Ferrer Spain	13	99 0.5×	96 0.9×	112 1.2×	65 0.8×	173 2.5×	24	542
Shinsuke Kiritoshi Japan	6	97 0.5×	205 2.0×	60 0.6×	61 0.7×	124 1.8×	6	575
Fumitaka Okajima Japan	13	185 0.9×	61 0.6×	74 0.8×	93 1.1×	54 0.8×	38	399
Giorgia Pierelli Italy	6	71 0.3×	156 1.5×	145 1.5×	50 0.6×	77 1.1×	7	494
Sonia Sifuentes-Franco Mexico	8	94 0.4×	153 1.5×	36 0.4×	51 0.6×	111 1.6×	19	512
H.‐J. Mest Germany	12	173 0.8×	138 1.3×	152 1.6×	141 1.6×	73 1.0×	61	559
Murat Olukman Türkiye	12	54 0.3×	81 0.8×	95 1.0×	64 0.7×	98 1.4×	27	448

Countries citing papers authored by Chie Ohmura

Since Specialization

Citations

This map shows the geographic impact of Chie Ohmura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chie Ohmura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chie Ohmura more than expected).

Fields of papers citing papers by Chie Ohmura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chie Ohmura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chie Ohmura. The network helps show where Chie Ohmura may publish in the future.

Co-authorship network of co-authors of Chie Ohmura

This figure shows the co-authorship network connecting the top 25 collaborators of Chie Ohmura. A scholar is included among the top collaborators of Chie Ohmura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chie Ohmura. Chie Ohmura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mita, Tomoya, Hidenori Yoshii, Yuki Someya, et al.. (2021). Olfactory dysfunction predicts the development of dementia in older patients with type 2 diabetes. Diabetes Research and Clinical Practice. 174. 108740–108740. 10 indexed citations

Kanazawa, Akio, Hideyoshi Kaga, Tomoya Mita, et al.. (2018). Postprandial Plasma Glucagon Kinetics in Type 2 Diabetes Mellitus: Comparison of Immunoassay and Mass Spectrometry. Journal of the Endocrine Society. 3(1). 42–51. 9 indexed citations

Kanazawa, Akio, Nayumi Shigihara, Fumihiko Sato, et al.. (2017). Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin. Journal of Clinical Medicine Research. 9(3). 193–199. 6 indexed citations

Sato, Junko, Akio Kanazawa, Koji Komiya, et al.. (2017). One year follow-up after a randomized controlled trial of a 130 g/day low-carbohydrate diet in patients with type 2 diabetes mellitus and poor glycemic control. PLoS ONE. 12(12). e0188892–e0188892. 19 indexed citations

Kanazawa, Akio, Yusuke Osonoi, Kosuke Azuma, et al.. (2017). Safety and efficacy of metformin up-titration in Japanese patients with type 2 diabetes mellitus treated with vildagliptin and low-dose metformin. Expert Opinion on Pharmacotherapy. 18(18). 1921–1928. 4 indexed citations

Yoshii, Hidenori, Tomoya Mita, Masahiko Gosho, et al.. (2015). Relationship between dietary pattern and cognitive function in elderly patients with type 2 diabetes mellitus. Journal of International Medical Research. 43(4). 506–517. 8 indexed citations

Mita, Tomoya, Hidenori Yoshii, Tomio Onuma, et al.. (2014). Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 106(3). 465–473. 41 indexed citations

Hirose, Takahisa, Fumihiko Sato, Yuki Someya, et al.. (2013). Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide. Journal of Diabetes Investigation. 5(4). 400–409. 12 indexed citations

Matsumoto, Kazuhisa, Akio Kanazawa, Fuki Ikeda, et al.. (2013). The area of abdominal subcutaneous adipose tissue is independently correlated with C-peptide increment during glucagon load in Japanese patients with type 2 diabetes. Diabetology International. 4(4). 243–250.

10.

Abe, Hiroko, Tomoya Mita, Risako Yamamoto, et al.. (2012). Comparison of effects of cilnidipine and azelnidipine on blood pressure, heart rate and albuminuria in type 2 diabetics with hypertension: A pilot study. Journal of Diabetes Investigation. 4(2). 202–205. 11 indexed citations

11.

Kanazawa, Akio, Fuki Ikeda, Chie Ohmura, et al.. (2012). Analysis of clinical factors contributing to the postglucagon increment in C-peptide levels in Japanese patients with type 2 diabetes: comparison with basal C-peptide levels and 24-h urinary C-peptide excretion. Diabetology International. 4(1). 60–65. 2 indexed citations

12.

Yoshida, Michiko, Tomoya Mita, Risako Yamamoto, et al.. (2011). Combination of the Framingham Risk Score and Carotid Intima-Media Thickness Improves the Prediction of Cardiovascular Events in Patients With Type 2 Diabetes. Diabetes Care. 35(1). 178–180. 60 indexed citations

13.

Ohmura, Chie, Hirotaka Watada, Tomoaki Shimizu, et al.. (2007). Calcium Channel Blocker, Azelnidipine, Reduces Lipid Hydroperoxides in Patients with Type 2 Diabetes Independent of Blood Pressure. Endocrine Journal. 54(5). 805–811. 12 indexed citations

14.

Shimada, Satoshi, Yasushi Tanaka, Chie Ohmura, et al.. (2005). N-(carboxymethyl)valine residues in hemoglobin (CMV-Hb) reflect accumulation of oxidative stress in diabetic patients. Diabetes Research and Clinical Practice. 69(3). 272–278. 13 indexed citations

15.

Ohmura, Chie, Hirotaka Watada, Takahisa Hirose, Yasushi Tanaka, & Ryuzo Kawamori. (2005). Acute Onset and Worsening of Diabetes Concurrent with Administration of Statins. Endocrine Journal. 52(3). 369–372. 24 indexed citations

16.

Watanabe, Kenji, Hiroshi Uchino, Chie Ohmura, et al.. (2004). Different effects of two α-glucosidase inhibitors, acarbose and voglibose, on serum 1,5-anhydroglucitol (1,5AG) level. Journal of Diabetes and its Complications. 18(3). 183–186. 27 indexed citations

17.

Inouye, Masayuki, et al.. (2003). Relationship between carotid atherosclerosis and erythrocyte membrane cholesterol oxidation products in type 2 diabetic patients. Diabetes Research and Clinical Practice. 61(2). 81–88. 18 indexed citations

18.

Yoshii, Hidenori, Hiroshi Uchino, Chie Ohmura, et al.. (2001). Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity. Diabetes Research and Clinical Practice. 51(2). 115–123. 30 indexed citations

19.

Tanaka, Yasushi, Hiroshi Uchino, Tomoaki Shimizu, et al.. (1999). Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats. European Journal of Pharmacology. 376(1-2). 17–22. 72 indexed citations

20.

Ohmura, Chie, Yasushi Tanaka, N Mitsuhashi, et al.. (1998). Efficacy of low-dose metformin in Japanese patients with type 2 diabetes mellitus. Current Therapeutic Research. 59(12). 889–895. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact